Psychometric testing of the ICECAP-A in patients with coeliac disease: a comparative analysis with EQ-5D-5L
This study is the first to validate ICECAP-A in patients with CD, demonstrating good psychometric performance, including strong convergent and known-group validity. Its ability to capture broader aspects of well-being supports its use as a valuable tool in outcome assessments for this patient population.
Authors
- M. Mercédesz Angyal (ORCID: https://orcid.org/0000-0001-7161-6767)
- Péter L. Lakatos (ORCID: https://orcid.org/0000-0002-3948-6488)
- Fanni Rencz (ORCID: https://orcid.org/0000-0001-9674-620X)
- Stevanus Pangestu (ORCID: https://orcid.org/0000-0003-2546-9449)
- Valentin Brodszky (ORCID: https://orcid.org/0000-0002-6095-2295)
Institutions
- Semmelweis University (HU)
- Corvinus University of Budapest (HU)
- Montreal General Hospital (CA)
- McGill University Health Centre (CA)
Publication Details
- Journal
- Health and Quality of Life Outcomes
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1186/s12955-025-02443-2
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00